Citadel Advisors’s MediWound MDWD Stock Holding History

Citadel Advisors’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,500	Closed	-$203K	–	13567
2025 Q2	$203K	Buy	10,500 +8,000	+320%	+$151K	﹤0.01%	10649
2025 Q1	$38.8K	Buy	+2,500	New	+$44.7K	﹤0.01%	12570
2024 Q4	–	Sell	-1,900	Closed	-$34.3K	–	15041
2024 Q3	$34.3K	Sell	1,900 -21,000	-92%	-$383K	﹤0.01%	12310
2024 Q2	$355K	Buy	22,900 +17,900	+358%	+$296K	﹤0.01%	8794
2024 Q1	$71.3K	Buy	+5,000	New	+$68.5K	﹤0.01%	11798
2022 Q2	–	Sell	-1,786	Closed	-$25K	–	13619
2022 Q1	$25K	Sell	1,786 -1,000	-36%	-$16.2K	﹤0.01%	13176
2021 Q4	$46K	Sell	2,786 -200	-7%	-$4.16K	﹤0.01%	13293
2021 Q3	$70K	Buy	+2,986	New	+$79.7K	﹤0.01%	13156

Other funds holding MDWD

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's MDWD Position: Q1 2026 in Review

Citadel Advisors reduced its MediWound (MDWD) stake by 34% in Q1 2026, selling an estimated $529K and leaving 59,240 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #7760.

Citadel Advisors first reported a position in MDWD in Q1 2014 and has held it in 23 quarters since. The position peaked at $8.19M in Q1 2014. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

Citadel Advisors held 59,240 shares of MediWound worth $954K as of Q1 2026.
Citadel Advisors sold 30,398 MediWound shares in Q1 2026, an estimated $529K.
MediWound made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7760 holding.
Citadel Advisors first reported a position in MediWound in Q1 2014 and has held it in 23 quarters since.
Citadel Advisors's MediWound position peaked at $8.19M in Q1 2014.
76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.